1: Geiger H, Fierlbeck W, Mai M, Ruchti H, Schönfeld V, Dämmrich J, Hugo C, Neumayer HH. Effects of early and late antihypertensive treatment on extracellular matrix proteins and mononuclear cells in uninephrectomized SHR. Kidney Int. 1997 Mar;51(3):750-61. PubMed PMID: 9067907.
2: Hoenack C, Roesen P. Inhibition of angiotensin type 1 receptor prevents decline of glucose transporter (GLUT4) in diabetic rat heart. Diabetes. 1996 Jan;45 Suppl 1:S82-7. PubMed PMID: 8529806.
3: Brilla CG, Zhou G, Rupp H, Maisch B, Weber KT. Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. Am J Cardiol. 1995 Nov 2;76(13):8D-13D. Review. PubMed PMID: 7495221.
4: Shaw LM, George PR, Oldham AA, Heagerty AM. A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries. J Hypertens. 1995 Oct;13(10):1135-43. PubMed PMID: 8586805.
5: Toubro S, Christensen NJ, Astrup A. Reproducibility of 24-h energy expenditure, substrate utilization and spontaneous physical activity in obesity measured in a respiration chamber. Int J Obes Relat Metab Disord. 1995 Aug;19(8):544-9. PubMed PMID: 7489024.
6: Bauer JH, Reams GP. The angiotensin II type 1 receptor antagonists. A new class of antihypertensive drugs. Arch Intern Med. 1995 Jul 10;155(13):1361-8. Review. PubMed PMID: 7794084.
7: Regitz-Zagrosek V, Auch-Schwelk W, Hess B, Klein U, Duske E, Steffen C, Hildebrandt AG, Fleck E. Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists. J Cardiovasc Pharmacol. 1995 Jul;26(1):66-72. PubMed PMID: 7564368.
8: Doughty SE, Ferrier RK, Hillan KJ, Jackson DG. The effects of ZENECA ZD8731, an angiotensin II antagonist, on renin expression by juxtaglomerular cells in the rat: comparison of protein and mRNA expression as detected by immunohistochemistry and in situ hybridization. Toxicol Pathol. 1995 May-Jun;23(3):256-61. PubMed PMID: 7659950.
9: Auch-Schwelk W, Duske E, Hink U, Betz M, Unkelbach M, Fleck E. Vasomotor responses in cyclosporin A-treated rats after chronic angiotensin blockade. Hypertension. 1994 Jun;23(6 Pt 2):832-7. PubMed PMID: 8206613.
10: Maxfield EK, Cameron NE, Cotter MA, Dines KC. Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function. Diabetologia. 1993 Dec;36(12):1230-7. PubMed PMID: 8307249.
11: Pörsti I, Hecker M, Bassenge E, Busse R. Dual action of angiotensin II on coronary resistance in the isolated perfused rabbit heart. Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):650-8. PubMed PMID: 7510856.
12: Masek BB, Merchant A, Matthew JB. Molecular shape comparison of angiotensin II receptor antagonists. J Med Chem. 1993 Apr 30;36(9):1230-8. PubMed PMID: 8487259.
13: Bradbury RH, Allott CP, Dennis M, Fisher E, Major JS, Masek BB, Oldham AA, Pearce RJ, Rankine N, Revill JM, et al. New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)quinoline derivatives. J Med Chem. 1992 Oct 30;35(22):4027-38. PubMed PMID: 1433210.